COMBINATION OF ORGANIC COMPOUNDS

摘要

The invention relates to a pharmaceutical combinations comprising an AT1 receptor blocker or pharmaceutically acceptable salts thereof and a mTOR inhibiting agent, e.g. rapamycin or a rapamycin derivative, optionally in th e presence of a pharmaceutically acceptable carrier.